Characterization of ethyl acetate and n-butanol extracts of Cymbopogon schoenanthus and Helianthemum lippii and their effect on the smooth muscle of the rat distal colon

ConclusionExtracts of H. lippii contain a higher level of phenols compared to the extracts of C. schoenanthus. All extracts of C. schoenanthus and H. lippii caused marked relaxation of the isolated rat distal colon, either when applied directly or when tested over KCl- and Ach-induced precontraction. These results give support to the use of C. shoenanthus and H. lippii in traditional medicine, namely for gastrointestinal diseases.Graphical abstract
Source: Journal of Ethnopharmacology - Category: Drugs & Pharmacology Source Type: research

Related Links:

Authors: Lisicki M, Schoenen J Abstract Introduction: Most preventive migraine treatments modify the brain's excitation/inhibition balance and/or serotonin metabolism, which likely accounts for their unfavourable adverse effect profile. Novel biological therapies blocking CGRP transmission are effective and much better tolerated, but they are expensive and may not influence brain dysfunctions upstream in the pathophysiological cascade of migraine, including premonitory and aura symptoms. Biochemical and clinical studies suggest that there may be another complimentary treatment strategy, the one that targets the undere...
Source: Expert Review of Neurotherapeutics - Category: Neurology Tags: Expert Rev Neurother Source Type: research
Publication date: March 2020Source: The Lancet Neurology, Volume 19, Issue 3Author(s): Ankur Khajuria
Source: The Lancet Neurology - Category: Neurology Source Type: research
Publication date: March 2020Source: The Lancet Neurology, Volume 19, Issue 3Author(s): Hugues Chabriat, Claudio L Bassetti, Ute Marx, Marie-Laure Audoli-Inthavong, Aurore Sors, Estelle Lambert, Marine Wattez, Dirk M Hermann, Katharina ALTHAUS, Sergi AMARO, Hee-Joon BAE, Zbigniew BAK, Leonardo BARBARINI, Pietro BASSI, Rodrigo BAZAN, Daniel BERECZKI, Tomasz BERKOWICZ, Joerg BERROUSCHOT, Dylan BLACQUIERE, Waldemar BROLASummaryBackgroundS44819, a selective GABAA α5 receptor antagonist, reduces tonic post-ischaemic inhibition of the peri-infarct cortex. S44819 improved stroke recovery in rodents and increased cortical exc...
Source: The Lancet Neurology - Category: Neurology Source Type: research
Publication date: March 2020Source: The Lancet Neurology, Volume 19, Issue 3Author(s):
Source: The Lancet Neurology - Category: Neurology Source Type: research
Publication date: March 2020Source: The Lancet Neurology, Volume 19, Issue 3Author(s):
Source: The Lancet Neurology - Category: Neurology Source Type: research
Publication date: March 2020Source: The Lancet Neurology, Volume 19, Issue 3Author(s): Matthew J Rowland, Tonny Veenith, Peter J Hutchinson, Gavin D Perkins, SOS Trial Investigators
Source: The Lancet Neurology - Category: Neurology Source Type: research
Publication date: March 2020Source: The Lancet Neurology, Volume 19, Issue 3Author(s): Joanna Laurson-Doube, Nick Rijke, Kathleen Costello, Jennifer McDonell, Gavin Giovannoni, Brenda Banwell, Peer Baneke
Source: The Lancet Neurology - Category: Neurology Source Type: research
Publication date: March 2020Source: The Lancet Neurology, Volume 19, Issue 3Author(s): Peter J Goadsby, Ali R Rezai, David W Dodick
Source: The Lancet Neurology - Category: Neurology Source Type: research
Publication date: March 2020Source: The Lancet Neurology, Volume 19, Issue 3Author(s): Arne May
Source: The Lancet Neurology - Category: Neurology Source Type: research
Publication date: March 2020Source: The Lancet Neurology, Volume 19, Issue 3Author(s): Steven C Cramer
Source: The Lancet Neurology - Category: Neurology Source Type: research
More News: Algeria Health | Drugs & Pharmacology | Flavonoids | Gastroenterology | Men | Study